Shaul Shani

Portfolio · 2

MSICS Pharma

GMP Naturally Sourced Psilocybin Pioneers

1 round $3.6M committed Latest: 2026-05

Comilion

Collaborative and Decentralized Cyber Threat Detection Platform

1 round $2.6M committed Latest: 2013-11

Investment activity

1 portfolio exit on record.

Q&A

What is Shaul Shani's most notable exit?

Shaul Shani had a notable exit in January 2017 with the acquisition of Comilion by Dell Technologies. Comilion was a collaborative and decentralized cyber threat detection platform.

Which sectors has Shaul Shani focused on for investments?

Shaul Shani has invested in the Cyber Security and Health Tech & Life Sciences sectors, with one portfolio company in each.

What is one of Shaul Shani's recent portfolio companies?

Shaul Shani invested in MSICS Pharma, a company founded in 2022 that focuses on GMP naturally sourced psilocybin. This investment was a Seed round.

What was the funding stage for Comilion before its acquisition?

Comilion, which was acquired by Dell Technologies, had raised $2.6M in funding prior to its acquisition.

What is the investment range for Shaul Shani?

Shaul Shani's investment range is between $2.6M and $3.6M.

Has Shaul Shani participated in any A Round investments?

Yes, Shaul Shani has participated in at least one A Round investment.